Skip to main content

Roche’s Virtual Event following ASH 2020 Webcast Replay

Roche has hosted a virtual event on Tuesday, 8 December 2020.

agenda
Agenda:
WelcomeKarl Mahler, Head of Investor Relations and Roche Group Planning
Hematology Franchise OverviewThomas Fuchs, Vice President, Hematology Franchise Head, Global Product Strategy
Review of Key Clinical Data Presented at ASHGinna Laport, Vice President & Global Head of Hematology NHL/CLL Marion Ott, M.D., PhD - Global Franchise Head AML, Multiple Myeloma and Pediatric Development
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Related links

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Roche’s Annual Report 2019

    Investors

    How medicines are making an impact in the lives of patients

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions